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Writing in the BMJ, 1 Jansen and col leagues point out: "There is limited evi dence to inform polypharmacy in older people, especially those with multimor bidity, cognitive impairment, or frailty."
Setting aside the potential negative consequences of inappropriate poly pharmacy, it seems there are substantial benefits to reducing drug regimens in older patients Jansen et al. add that: "Systematic reviews of medication withdrawal trials (deprescribing) show that reducing spe cific classes of medicines may decrease adverse events and improve quality of life." However, they stress that patient involvement and shared decision making are essential components of the depre scribing process. As Barnett and Kelly illustrate in their case study, patients may become anxious and concerned when what they see as important and beneficial medicines are abruptly with drawn. After all, the confused patient may understandably argue that the drugs were prescribed at some point, presuma bly for a reason.
Psychoactive polypharmacy
One aspect not helping such confusion may be the effects of polypharmacy itself. A recent study in the USA 2 found that multiple psychoactive drugs are commonly prescribed in the elderly, with the number of retired Americans taking at least three psychiatric drugs more than doubling between 2004 and 2013, even though almost half of them had no men tal health diagnosis on record. Writing in JAMA Internal Medicine, Maust and colleagues suggest this may in part be due to primary care clinicians coming under pressure to treat condi tions previously in the domain of psychi atry. Observing a situation that will be familiar to their UK counterparts, they say: "Because of limited access to spe cialty care and a preference to receive treatment in primary care settings, it is unsurprising that mental health treat ment has expanded in nonpsychiatric settings."
Time constraints
Whatever the reasons behind inappropri ate polypharmacy in the older population, there is a consensus that regular medi cation reviews in this demographic are essential. But these are time consuming, and careful, monitored deprescribing is not an easy or straightforward process. At a time when GPs are under impossible pressure, a click of the mouse to repeat a prescription may be the most tempting option.
